REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM NEW
Total 13F shares
2,654,240
Share change
+31,280
Total reported value
$2,706,169
Price per share
$1.02
Number of holders
22
Value change
+$42,170
Number of buys
11
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q1 2019

As of 31 Mar 2019, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,654,240 shares. The largest 10 holders included BVF INC/IL, NEA Management Company, LLC, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, JANE STREET GROUP, LLC, BlackRock Inc., VANGUARD GROUP INC, WEDBUSH SECURITIES INC, GEODE CAPITAL MANAGEMENT, LLC, and WELLS FARGO & COMPANY/MN. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.